Jason Lettmann's Net Worth
$6.99 Million
Who is Jason Lettmann?
Jason Lettmann has an estimated net worth of $6.99 Million. This is based on reported shares across multiple companies, which include ALX ONCOLOGY HOLDINGS INC, and Ra Pharmaceuticals, Inc..
SEC CIK
Jason Lettmann's CIK is 0001688269
Past Insider Trading and Trends
2016 was Jason Lettmann's most active year for acquiring shares with 11 total transactions. Jason Lettmann's most active month to acquire stocks was the month of September. 2021 was Jason Lettmann's most active year for disposing of shares, totalling 28 transactions. Jason Lettmann's most active month to dispose stocks was the month of November. 2020 saw Jason Lettmann paying a total of $7,600,000.00 for 4,203,884 shares, this is the most they've acquired in one year. In 2021 Jason Lettmann cashed out on 471,014 shares for a total of $13,599,895.09, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ALX ONCOLOGY HOLDINGS INC (ALXO) Snapshot price: $15.54
CHIEF EXECUTIVE OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.63% | 4.4K |
$11.31 | $49,771.48 | 171.62K |
Mar 14
| |||
Form 4
| +55.96% | 60K |
—
|
—
| 167.22K |
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| -2.22% | -325.38K |
$27.91 | -$8,901,803.95 | 14.36M |
Dec 13
| |||
Form 4
| -0.73% | -145.64K |
$32.17 | -$4,698,091.14 | 19.84M |
Dec 8 - Dec 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
| +398.72% | 4.18M |
$19.00 | $7,600,000.00 | 5.23M |
Jul 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ra Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +23,622.45% | 4.05M |
$12.11 | -$4,420.00 | 4.07M |
Oct 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||